Vertu Motors Plc Q&A with Zeus Capital (LON:VTU)
10 May 2019
Humacyte, Inc. (NASDAQ: HUMA), a pioneering biotechnology company in the healthcare sector, is capturing investor attention with its ambitious focus on bioengineered human tissues. Based in Durham, North Carolina, Humacyte..
Abivax SA (ABVX), a France-based biotechnology firm, is currently capturing the attention of investors with its promising potential upside of 32.67%. This clinical-stage company is renowned for its focus on..
In the dynamic world of biotechnology, Oruka Therapeutics, Inc. (NASDAQ: ORKA) is rapidly gaining attention. With its focus on developing cutting-edge monoclonal antibody therapeutics for psoriasis and other inflammatory conditions,..
AngioDynamics, Inc. (NASDAQ: ANGO), a key player in the healthcare sector, is making waves with its innovative medical technologies. With a market capitalization of $441.44 million, this Latham, New York-based..
Kamada Ltd. (NASDAQ: KMDA), a key player in the healthcare sector focusing on plasma-derived protein therapeutics, is drawing investor attention with its promising growth trajectory. Headquartered in Rehovot, Israel, Kamada..
Altimmune, Inc. (NASDAQ: ALT), a clinical-stage biopharmaceutical company, has been drawing significant attention in the biotechnology sector with its ambitious focus on tackling obesity, metabolic, and liver diseases. Headquartered in..
Bioventus Inc. (NASDAQ: BVS), a prominent player in the healthcare sector, is capturing the attention of investors with a notable 74.42% potential upside, according to recent analyst ratings. Headquartered in..
In the dynamic world of biotechnology, few companies offer the tantalizing upside potential that MeiraGTx Holdings plc (NASDAQ: MGTX) does. With a potential upside of 250.13%, this clinical-stage genetics medicines..
Oric Pharmaceuticals, Inc. (NASDAQ: ORIC) has been capturing the attention of investors with its promising pipeline and strategic partnerships in the biotechnology sector. As a clinical-stage biopharmaceutical company, Oric Pharmaceuticals..
Septerna, Inc. (NASDAQ: SEPN) stands as a dynamic player in the biotechnology sector, capturing investor attention with a staggering potential upside of 65.84%. As a clinical-stage company, Septerna is deeply..
Investors focusing on the biotechnology sector might want to take a closer look at Rapport Therapeutics, Inc. (NASDAQ: RAPP), a clinical-stage biopharmaceutical company that has been making waves with its..
Investors eyeing SIGA Technologies Inc. (NASDAQ: SIGA) should consider both its potential and challenges within the healthcare sector. As a commercial-stage pharmaceutical company specializing in health security, SIGA’s flagship product,..
Talkspace, Inc. (NASDAQ: TALK) is making waves in the digital healthcare sector, offering a unique investment opportunity as it continues to expand its footprint in the virtual behavioral health market...
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX), a clinical-stage pharmaceutical company based in Cambridge, Massachusetts, is capturing the attention of investors with its forward-looking pipeline in the healthcare sector. Specializing in the..
Investors exploring opportunities within the biotechnology sector might want to pay close attention to Upstream Bio, Inc. (NASDAQ: UPB), a clinical-stage biotech company focused on inflammatory diseases. With a market..
Avanos Medical, Inc. (NYSE: AVNS), a notable player in the healthcare sector, operates within the competitive medical devices industry. With a market capitalization of $624.54 million, the company is strategically..
Phibro Animal Health Corporation (NASDAQ: PAHC) stands as a significant player in the healthcare sector, particularly within the niche of drug manufacturing for both specialty and generic products. With a..
Tyra Biosciences, Inc. (NASDAQ: TYRA) has emerged as a compelling player in the biotechnology sector, captivating investor interest with its innovative approach to precision medicine. With a current market capitalization..
Treace Medical Concepts, Inc. (NASDAQ: TMCI) is a name that has been capturing attention within the healthcare sector, specifically in the medical devices industry. With a market capitalization of $87.2..
For investors with an appetite for high-risk, high-reward opportunities in the biotechnology sector, Autolus Therapeutics plc (NASDAQ: AUTL) offers a compelling narrative. Headquartered in London, this clinical-stage biopharmaceutical company focuses..
